Terms: = Prostate cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Treatment
39 results:
1. Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases.
Ji J; Liu T; Yao Y; Liu W; Ning H; Wang T; Zhang G
Neoplasia; 2024 Jan; 47():100961. PubMed ID: 38142529
[TBL] [Abstract] [Full Text] [Related]
2. Sclerosing Adenosis of the prostate-A Benign Lesion Similar to prostate cancer: A Case Report and Literature Review.
Yao H; Tang G; Cui Y; Wu J
Am J Mens Health; 2022; 16(6):15579883221143182. PubMed ID: 36527372
[TBL] [Abstract] [Full Text] [Related]
3. Cytomorphology, immunoprofile, and clinicopathologic correlation of metastatic prostatic carcinoma.
Lin X; Shi Q; Yang XJ
Hum Pathol; 2022 Dec; 130():36-46. PubMed ID: 36244466
[TBL] [Abstract] [Full Text] [Related]
4. Expansion of mouse castration-resistant intermediate prostate stem cells in vitro.
Xu Y; Mu J; Zhou Z; Leng Y; Yu Y; Song X; Liu A; Zhu H; Li J; Wang D
Stem Cell Res Ther; 2022 Jul; 13(1):299. PubMed ID: 35841025
[TBL] [Abstract] [Full Text] [Related]
5. Primary squamous cell carcinoma of the testis: a rare presentation.
Zahoor A; Swamy R; Gogbashian A; Sharma A
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35459646
[TBL] [Abstract] [Full Text] [Related]
6. p63-positive prostate carcinoma-A very rare presentation.
Lokesha SB; Chowdary BV; Kini JR
Indian J Pathol Microbiol; 2022; 65(2):448-451. PubMed ID: 35435392
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological Features and Expression of P504s,E-cadherin,Erythroblast Transformation-specific Related Gene and Estrogen Receptor in prostate Adenocarcinoma in Tibet].
Luo HH; Huo Z; Xiao Y; Nimazhuoma ; Wang Q; Dazhen ; Cirenquzhen
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):761-766. PubMed ID: 34728038
[TBL] [Abstract] [Full Text] [Related]
8. [Our experience with cytoreductive radical prostatectomy in patients with oligometastatic prostate cancer].
Berczi C; Dócs J; Flaskó T
Orv Hetil; 2021 Mar; 162(13):483-487. PubMed ID: 33774598
[TBL] [Abstract] [Full Text] [Related]
9. Human papilloma virus (HPV) integration signature in Cervical cancer: identification of MACROD2 gene as HPV hot spot integration site.
Kamal M; Lameiras S; Deloger M; Morel A; Vacher S; Lecerf C; Dupain C; Jeannot E; Girard E; Baulande S; Dubot C; Kenter G; Jordanova ES; Berns EMJJ; Bataillon G; Popovic M; Rouzier R; Cacheux W; Le Tourneau C; Nicolas A; Servant N; Scholl SM; Bièche I;
Br J Cancer; 2021 Feb; 124(4):777-785. PubMed ID: 33191407
[TBL] [Abstract] [Full Text] [Related]
10. Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy.
Čamdžić N; Kuskunović-Vlahovljak S; Dorić M; Radović S; Lazović Salčin E; Babić M
Med Glas (Zenica); 2021 Feb; 18(1):122-127. PubMed ID: 32815673
[TBL] [Abstract] [Full Text] [Related]
11. Primary Extracranial Meningioma of Mastoid in a Patient With History of Skin Squamous Cell Carcinoma, Lung Adenocarcinoma and Prostatic Carcinoma.
Hu M; Tang Y; Long G; Zhang D; Kresak JL; Lai J
Anticancer Res; 2019 Jun; 39(6):3197-3201. PubMed ID: 31177167
[TBL] [Abstract] [Full Text] [Related]
12. Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens.
Leng E; Henriksen JC; Rizzardi AE; Jin J; Nam JW; Brassuer BM; Johnson AD; Reder NP; Koopmeiners JS; Schmechel SC; Metzger GJ
Sci Rep; 2019 May; 9(1):6992. PubMed ID: 31061447
[TBL] [Abstract] [Full Text] [Related]
13. MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.
David SN; Arnold Egloff SA; Goyal R; Clark PE; Phillips S; Gellert LL; Hameed O; Giannico GA
Prostate; 2018 Jun; 78(8):616-622. PubMed ID: 29542165
[TBL] [Abstract] [Full Text] [Related]
14. Vasitis nodosa and related lesions: a modern immunohistochemical staining profile with special emphasis on novel diagnostic dilemmas.
Kezlarian BE; Cheng L; Gupta NS; Williamson SR
Hum Pathol; 2018 Mar; 73():164-170. PubMed ID: 29241741
[TBL] [Abstract] [Full Text] [Related]
15. New and Emerging Diagnostic and Prognostic Immunohistochemical Biomarkers in prostate Pathology.
Giannico GA; Arnold SA; Gellert LL; Hameed O
Adv Anat Pathol; 2017 Jan; 24(1):35-44. PubMed ID: 27941540
[TBL] [Abstract] [Full Text] [Related]
16. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
[TBL] [Abstract] [Full Text] [Related]
17. Epithelioid Angiosarcoma of the Bladder: A Series of 9 Cases.
Matoso A; Epstein JI
Am J Surg Pathol; 2015 Oct; 39(10):1377-82. PubMed ID: 25929352
[TBL] [Abstract] [Full Text] [Related]
18. A human fetal prostate xenograft model of developmental estrogenization.
Saffarini CM; McDonnell-Clark EV; Amin A; Boekelheide K
Int J Toxicol; 2015; 34(2):119-28. PubMed ID: 25633637
[TBL] [Abstract] [Full Text] [Related]
19. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG
J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389
[TBL] [Abstract] [Full Text] [Related]
20. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
Epstein JI; Egevad L; Humphrey PA; Montironi R;
Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
[TBL] [Abstract] [Full Text] [Related]
[Next]
